The application of multiple miRNA response elements enables oncolytic adenoviruses to possess specificity to glioma cells

Virology

Volumn 458-459, Issue 1, 2014, Pages 69-82

  Yao, Weicheng ^a   Guo, Guocai ^a   Zhang, Quanqin ^a   Fan, Lingyan ^a   Wu, Ning ^b   Bo, Yongli ^a  

^a QINGDAO UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Adenovirus; Glioma; miRNA

Indexed keywords

E1A PROTEIN; LONTUCIREV; MICRORNA; MICRORNA 124; MICRORNA 128; MICRORNA 146B; MICRORNA 218; ONCOLYTIC ADENOVIRUS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SAFETY; DRUG SPECIFICITY; EMBRYO; FEMALE; GENE EXPRESSION REGULATION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICRORNA RESPONSE ELEMENT; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA STRUCTURE; TUMOR XENOGRAFT; VIRUS REPLICATION;

ADENOVIRUS; GLIOMA; MIRNA;

ADENOVIRIDAE; ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MICE; MICRORNAS; NEOPLASMS, EXPERIMENTAL; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; RESPONSE ELEMENTS;

EID: 84899879542     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.04.007     Document Type: Article

References (37)

1. Alvarez-Breckenridge C.A., Yu J., Price R., Wojton J., Pradarelli J., Mao H., Wei M., Wang Y., He S., Hardcastle J., Fernandez S.A., Kaur B., Lawler S.E., Vivier E., Mandelboim O., Moretta A., Caligiuri M.A., Chiocca E.A. NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Nat. Med. 2012, 18:1827-1834.
2. Cawood R., Wong S.L., Di Y., Baban D.F., Seymour L.W. MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity. PLoS One 2011, 6:e16152.
3. Chen W., Wu Y., Liu W., Wang G., Wang X., Yang Y., Chen W., Tai Y., Lu M., Qian Q., Zhang Q., Chen G. Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma. Cancer Lett. 2011, 307:93-103.
4. Cheng L.C., Pastrana E., Tavazoie M., Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 2009, 12:399-408.
5. Ciafre S.A., Galardi S., Mangiola A., Ferracin M., Liu C.G., Sabatino G., Negrini M., Maira G., Croce C.M., Farace M.G. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 2005, 334:1351-1358.
6. Conti A., Aguennouz M., La Torre D., Tomasello C., Cardali S., Angileri F.F., Maio F., Cama A., Germano A., Vita G., Tomasello F. miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J. Neurooncol. 2009, 93:325-332.
7. Fulci G., Dmitrieva N., Gianni D., Fontana E.J., Pan X., Lu Y., Kaufman C.S., Kaur B., Lawler S.E., Lee R.J., Marsh C.B., Brat D.J., van Rooijen N., Stemmer-Rachamimov A.O., Hochberg F.H., Weissleder R., Martuza R.L., Chiocca E.A. Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses. Cancer Res. 2007, 67:9398-9406.
8. Godlewski J., Nowicki M.O., Bronisz A., Williams S., Otsuki A., Nuovo G., Raychaudhury A., Newton H.B., Chiocca E.A., Lawler S. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008, 68:9125-9130.
9. Gomez-Manzano C., Fueyo J. Oncolytic adenoviruses for the treatment of brain tumors. Curr. Opin. Mol. Ther. 2010, 12:530-537.
10. He X., Liu J., Yang C., Su C., Zhou C., Zhang Q., Li L., Wu H., Liu X., Wu M., Qian Q. 5/35 Fiber-modified conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells. Hum. Gene Ther. 2011, 22:283-292.
11. Jin H., Lv S., Yang J., Wang X., Hu H., Su C., Zhou C., Li J., Huang Y., Li L., Liu X., Wu M., Qian Q. Use of microRNA Let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells. PLoS One 2011, 6:e21307.
12. Kefas B., Godlewski J., Comeau L., Li Y., Abounader R., Hawkinson M., Lee J., Fine H., Chiocca E.A., Lawler S., Purow B. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 2008, 68:3566-3572.
13. Leja J., Nilsson B., Yu D., Gustafson E., Akerstrom G., Oberg K., Giandomenico V., Essand M. Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability. PLoS One 2010, 5:e8916.
14. Liu D.Z., Ander B.P., Tian Y., Stamova B., Jickling G.C., Davis R.R., Sharp F.R. Integrated analysis of mRNA and microRNA expression in mature neurons, neural progenitor cells and neuroblastoma cells. Gene 2012, 495:120-127.
15. Liu J., Ma L., Li C., Zhang Z., Yang G., Zhang W. Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells. Mol. Oncol. 2013, 7:1043-1055.
16. Luo J., Xia Q., Zhang R., Lv C., Zhang W., Wang Y., Cui Q., Liu L., Cai R., Qian C. Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene. Clin. Cancer Res. 2008, 14:2450-2457.
17. Ma L., Liu J., Shen J., Liu L., Wu J., Li W., Luo J., Chen Q., Qian C. Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol. Ther. 2010, 9:554-561.
18. Malzkorn B., Wolter M., Liesenberg F., Grzendowski M., Stuhler K., Meyer H.E., Reifenberger G. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol. 2010, 20:539-550.
19. McCutcheon I.E., Friend K.E., Gerdes T.M., Zhang B.M., Wildrick D.M., Fuller G.N. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth. J. Neurosurg. 2000, 92:306-314.
20. Nan Y., Han L., Zhang A., Wang G., Jia Z., Yang Y., Yue X., Pu P., Zhong Y., Kang C. MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res. 2010, 1359:14-21.
21. Post D.E., Khuri F.R., Simons J.W., Van Meir E.G. Replicative oncolytic adenoviruses in multimodal cancer regimens. Hum. Gene Ther. 2003, 14:933-946.
22. Rao S.A., Santosh V., Somasundaram K. Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod. Pathol. 2010, 23:1404-1417.
23. Reardon D.A., Galanis E., DeGroot J.F., Cloughesy T.F., Wefel J.S., Lamborn K.R., Lassman A.B., Gilbert M.R., Sampson J.H., Wick W., Chamberlain M.C., Macdonald D.R., Mehta M.P., Vogelbaum M.A., Chang S.M., Van den Bent M.J., Wen P.Y. Clinical trial end points for high-grade glioma: the evolving landscape. Neuro Oncol. 2011, 13:353-361.
24. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004, 5:R13.
25. Silber J., Lim D.A., Petritsch C., Persson A.I., Maunakea A.K., Yu M., Vandenberg S.R., Ginzinger D.G., James C.D., Costello J.F., Bergers G., Weiss W.A., Alvarez-Buylla A., Hodgson J.G. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008, 6:14.
26. Skalsky R.L., Cullen B.R. Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene. PLoS One 2011, 6:e24248.
27. Small E.M., Sutherland L.B., Rajagopalan K.N., Wang S., Olson E.N. MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling. Circ. Res. 2010, 107:1336-1344.
28. Smirnova L., Grafe A., Seiler A., Schumacher S., Nitsch R., Wulczyn F.G. Regulation of miRNA expression during neural cell specification. Eur. J. Neurosci. 2005, 21:1469-1477.
29. Su C.Q., Sham J., Xue H.B., Wang X.H., Chua D., Cui Z.F., Peng L.H., Li L.F., Jiang L.H., Wu M.C., Qian Q.J. Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells. J. Cancer Res. Clin. Oncol. 2004, 130:591-603.
30. Wu N., Zhao X., Liu M., Liu H., Yao W., Zhang Y., Cao S., Lin X. Role of microRNA-26b in glioma development and its mediated regulation on EphA2. PLoS One 2011, 6:e16264.
31. Xia H., Qi Y., Ng S.S., Chen X., Li D., Chen S., Ge R., Jiang S., Li G., Chen Y., He M.L., Kung H.F., Lai L., Lin M.C. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res. 2009, 1269:158-165.
32. Xu C., Sun Y., Wang Y., Yan Y., Shi Z., Chen L., Lin H., Lu S., Zhu M., Su C., Li Z. CEA promoter-regulated oncolytic adenovirus-mediated Hsp70 expression in immune gene therapy for pancreatic cancer. Cancer Lett. 2012, 319:154-163.
33. Ylosmaki E., Hakkarainen T., Hemminki A., Visakorpi T., Andino R., Saksela K. Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA. J. Virol. 2008, 82:11009-11015.
34. Yoo A.S., Sun A.X., Li L., Shcheglovitov A., Portmann T., Li Y., Lee-Messer C., Dolmetsch R.E., Tsien R.W., Crabtree G.R. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 2011, 476:228-231.
35. Yue X., Wang P., Xu J., Zhu Y., Sun G., Pang Q., Tao R. MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A. Oncol. Rep. 2012, 27:1200-1206.
36. Zhang W., Cai R., Luo J., Wang Y., Cui Q., Wei X., Zhang H., Qian C. The oncolytic adenovirus targeting to TERT and RB pathway induced specific and potent anti-tumor efficacy in vitro and in vivo for hepatocellular carcinoma. Cancer Biol. Ther. 2007, 6:1726-1732.
37. Zheng F., Liao Y.J., Cai M.Y., Liu Y.H., Liu T.H., Chen S.P., Bian X.W., Guan X.Y., Lin M.C., Zeng Y.X., Kung H.F., Xie D. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 2012, 61:278-289.